DK
Dakshidin Corporation
DKSC · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $1.33M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
54 /100
Fair P/B 195.64x
EV/EBITDA 9.83x
P/S N/A
Growth
0 /100
Declining Book val. growth 63.68%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 4.27%
Asset turnover 0.00x
ROIC 11.51%
Debt
39 /100
Moderate Current ratio -0.00x
Net debt/EBITDA 0.98x
Debt/Equity 21.66x
Stability
33 /100
Unstable Profitable years 0
Beta -0.51x
EPS volatility N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about DKSC
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Christopher Robin Haigh
Employees
0
Headquarters
Miami